Letter to the Editor
Sir: Schizophrenia is associated with increased prevalenceof smoking, heavy smoking, and smoking-related morbidity andmortality. Standard nicotine dependence treatments have beenassociated with modest efficacy in patients with schizophreniaand high rates of relapse to smoking upon their discontinuation.Varenicline was approved for nicotine dependencetreatment in 2006.
Save
Cite
Advertisement
GAM ID: sidebar-top